Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01838395
Brief Title: Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients

First Submitted : April 14, 2013
First Submitted that Met QC Criteria : April 19, 2013
First Posted : April 24, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : June 14, 2016
Last Update Posted : June 15, 2016 (Estimate)